The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin
Clinical trial NCT03869268 · COMPLETED
Trial details
- NCT number
- NCT03869268
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-24
- Primary completion
- 2021-12-10
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.